A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer
✍ Scribed by Philippe A. Cassier; Isabelle Ray-Coquard; Marie-Pierre Sunyach; Laurence Lancry; Jean-Paul Guastalla; Céline Ferlay; Frédéric Gomez; Hervé Curé; Alain Lortholary; Line Claude; Jean-Yves Blay; Thomas Bachelot
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 139 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The majority of breast cancer patients with brain metastases receive whole‐brain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retr
## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i
## Abstract ## BACKGROUND. This randomized pilot trial investigated whether primary chemotherapy was feasible in terms of efficacy, survival, toxicity profile, and quality of life compared with whole‐brain radiotherapy (WBRT) given first in chemotherapy‐naive patients nonsmall cell lung cancer (NS